Common use of Project Execution Clause in Contracts

Project Execution.  Duke CTSI and NC State staff will work closely with funded teams throughout the grant period to monitor progress and, when necessary, provide assistance. A six-month interim progress report and final progress report will be required. Duke CTSI and NC State expect PIs to report over the lifetime of the work the outcomes achieved due to the pilot award, e.g., subsequent external funding, publications, presentations and patents.  A Duke CTSI Project Leader will be assigned to each funded project. The investigators will interact regularly with the Duke CTSI Project Leader, who will work with the investigators to manage projects, report progress relative to planned milestones, and serve as a resource to identify and fulfill unmet project needs via the Duke CTSI and other key resources.  Duke’s CTSA grant Award Number UL1TR002553 notice of grant award included both federal funding and our institutional commitment. The institutional funds used in our CTSA pilot funding programs take on the identity of federal funds in this award mechanism and therefore should be treated as such with regards to IRB, IACUC, and tech transfer office reporting. NCATS approval is required prior to initiating research involving human subjects, and inventions resulting from pilot awards must be reported in iEdison and include UL1TR002553 as the source of federal funding.  All publications that are the direct result of this funding must reference: “Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number Award Number UL1TR002553. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.” Publications must also be registered in PubMed Central. After your publication is accepted, click here for a guide to complying with the NIH Public Access Policy  Any awardee who leaves his or her position should contact Duke CTSI to discuss future plans for the project.

Project Execution.  o Investigators agree to work in collaboration with the Duke CTSI and NC State staff will work closely with funded teams throughout the grant period Accelerator to monitor progress and, and when necessary, provide assistance. A six-month interim progress report Quarterly and final progress report reports will be required. Duke CTSI Investigators will present the interim findings of their work at six months and NC State expect PIs final results at 12 months, if requested. The investigators are expected to report over the lifetime of the work annually, for up to 5 years post-award, the outcomes achieved due to the pilot award, e.g., subsequent external funding, publications, presentations and patents.  A Duke CTSI may terminate and reallocate residual funds for any team failing to submit required written reports in a timely manner. Proposed aims of funded projects may be changed, added or deleted during the funding period, pending Investigator and Duke CTSI Program Leadership Committee review and agreement. Funding amount may be modified pending Investigator and Duke CTSI Program Leadership Committee agreement. Projects must be completed in the 12-month period; no-cost extensions will not be granted. o Investigators will meet with their Duke CTSI Project Leader will be assigned during the project run-in period to each funded projectreview project plans and ensure projects are ready to start July 1st. The investigators will interact regularly with the Duke CTSI Project Leader, who will work with the investigators to manage projects, report progress relative to planned milestones, and serve as a resource to identify and fulfill unmet project needs via the Duke CTSI and other key resources.  o Duke’s CTSA grant Award Number UL1TR002553 notice of grant award included both federal funding and our institutional commitment. The institutional funds used in our CTSA pilot funding programs take on the identity of federal funds in this award mechanism and therefore should be treated as such with regards to IRB, IACUC, and tech transfer office reporting. NCATS approval is may be required prior to initiating research involving human subjects, and inventions resulting from pilot awards must be reported in iEdison and include UL1TR002553 as the source of federal funding.  o All publications that are the direct result of this funding must reference: “Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number Award Number UL1TR002553. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.” Publications must also be registered in PubMed Central. After your publication is accepted, click here for a guide to complying with the NIH Public Access Policy  Policy. o Any awardee who leaves his or her position should contact Duke CTSI to discuss future plans for the project.

Project Execution.  ▪ Investigators agree to work in collaboration with the Duke CTSI and NC State staff will work closely with funded teams throughout the grant period Accelerator to monitor progress and, and when necessary, provide assistance. A six-month interim progress report Quarterly and final progress report reports will be required. Duke CTSI Investigators will present the interim findings of their work at six months and NC State expect PIs final results at 12 months, if requested. The investigators are expected to report over the lifetime of the work annually, for up to 5 years post-award, the outcomes achieved due to the pilot award, e.g., subsequent external funding, publications, presentations and patents.  A Duke CTSI may terminate and reallocate residual funds for any team failing to submit required written reports in a timely manner. Proposed aims of funded projects may be changed, added or deleted during the funding period, pending Investigator and Duke CTSI Program Leadership Committee review and agreement. Funding amount may be modified pending Investigator and Duke CTSI Program Leadership Committee agreement. Projects must be completed in the 12-month period; no-cost extensions will not be granted. ▪ Investigators will meet with their Duke CTSI Project Leader will be assigned during the project run-in period to each funded projectreview project plans and ensure projects are ready to start July 1st. The investigators will interact regularly with the Duke CTSI Project Leader, who will work with the investigators to manage projects, report progress relative to planned milestones, and serve as a resource to identify and fulfill unmet project needs via the Duke CTSI and other key resources.  ▪ Duke’s CTSA grant Award Number UL1TR002553 notice of grant award included both federal funding and our institutional commitment. The institutional funds used in our CTSA pilot funding programs take on the identity of federal funds in this award mechanism and therefore should be treated as such with regards to IRB, IACUC, and tech transfer office reporting. NCATS approval is may be required prior to initiating research involving human subjects, and inventions resulting from pilot awards must be reported in iEdison and include UL1TR002553 as the source of federal funding.  ▪ All publications that are the direct result of this funding must reference: “Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number Award Number UL1TR002553. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.” Publications must also be registered in PubMed Central. After your publication is accepted, click here for a guide to complying with the NIH Public Access Policy  Policy. ▪ Any awardee who leaves his or her position should contact Duke CTSI to discuss future plans for the project.

Project Execution.   Investigators agree to work in collaboration with the Duke CTSI and NC State staff will work closely with funded teams throughout the grant period Accelerator to monitor progress and, and when necessary, provide assistance. A six-month interim progress report Quarterly and final progress report reports will be required. Duke CTSI Investigators will present the interim findings of their work at six months and NC State expect PIs final results at 12 months, if requested. The investigators are expected to report over the lifetime of the work annually, for up to 5 years post-award, the outcomes achieved due to the pilot award, e.g., subsequent external funding, publications, presentations and patents.  A Duke CTSI may terminate and reallocate residual funds for any team failing to submit required written reports in a timely manner. Proposed aims of funded projects may be changed, added or deleted during the funding period, pending Investigator and Duke CTSI Program Leadership Committee review and agreement. Funding amount may be modified pending Investigator and Duke CTSI Program Leadership Committee agreement. Projects must be completed in the 12-month period; no-cost extensions will not be granted.  Investigators will meet with their Duke CTSI Project Leader will be assigned during the project run-in period to each funded projectreview project plans and ensure projects are ready to start July 1st. The investigators will interact regularly with the Duke CTSI Project Leader, who will work with the investigators to manage projects, report progress relative to planned milestones, and serve as a resource to identify and fulfill unmet project needs via the Duke CTSI and other key resources.   Duke’s CTSA grant Award Number UL1TR002553 notice of grant award included both federal funding and our institutional commitment. The institutional funds used in our CTSA pilot funding programs take on the identity of federal funds in this award mechanism and therefore should be treated as such with regards to IRB, IACUC, and tech transfer office reporting. NCATS approval is may be required prior to initiating research involving human subjects, and inventions resulting from pilot awards must be reported in iEdison and include UL1TR002553 as the source of federal funding.   All publications that are the direct result of this funding must reference: “Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number Award Number UL1TR002553. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.” Publications must also be registered in PubMed Central. After your publication is accepted, click here for a guide to complying with the NIH Public Access Policy  Policy.  Any awardee who leaves his or her position should contact Duke CTSI to discuss future plans for the project.